Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction - HORIZONS-AMI Stent

Description:

Although drug-eluting stents (DES) have been shown to be superior to bare-metal stents (BMS) in a number of settings, there is still no consensus regarding the use of DES in ST-elevation myocardial infarction (STEMI). The HORIZONS-AMI trial sought to compare the safety and efficacy of paclitaxel-eluting stents (PES) over BMS in patients presenting within 12 hours of symptom onset with STEMI.